THE government has confirmed the PBS listing of Eisai Australia's Fycompa (perampanel) for epilepsy effective from 01 Aug, with the potential to help 50,000 patients.
Also newly listed is Ryzodeg 70/30 (insulin degludec/aspart) from NovoNordisk, the first diabetes pen to contain two types of insulin.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jul 18